Abstract
Transfusion of red blood cells (RBCs) is now considered a well-established therapy and essential. Transfusion is needed for emergencies or hematologic disorders. However, so far the supply of RBCs remains unstable and dependent on voluntary donations. Adding to this, the aging of the blood donor population, as well as the transmission of infectious diseases is still a risk. Therefore, the…